Dr Vasili Karas Is Appointed to the ExplORer Surgical Advisory Board

Dr Vasili Karas, MD, MS, an orthopedic surgeon at Midwest Orthopaedics at Rush, has officially joined the company’s Clinical Advisory Board, alongside Dr. Hemal Gada, MD, MBA of UPMC Pinnacle.

Because Dr. Vasil Karas has extensive experience in rapid recovery orthopedic surgery, it provides ExplORer Surgical and its executive team a valuable resource to help bridge the gap between the company’s platform and its surgical team users.
Dr. Vasil Karas is a fellowship-trained orthopedic surgeon specializing in rapid recovery hip and knee replacement and complex reconstruction surgery. He earned his medical degree at Rush University’s Medical College in Chicago. After completing his residency at Duke University Medical Center in North Carolina, he returned to Rush in Chicago to finish his fellowship training in hip and knee replacement surgery. He has over 40 peer-reviewed publications and is a committee member of the American Academy of Hip and Knee Surgeons (AAHKS).
Dr. Vasil Karas first became familiar with  ExplORer’s workflow platform when he implemented the technology at Rush to assist with total knee and total hip procedures, evaluating its effectiveness after each procedure. Over the course of eight months, Dr. Karas and his team improved confidence in their procedures and reduced challenges stemming from unexpected procedural occurrences, surgeon preferences for instrumentation and room setup, and patient positioning, giving the technology a 9.1/10 score. The team also noted a 30 percent increase in comfort supporting Dr. Karas, and Dr. Karas noted an 80 percent decrease in instrumentation and room setup challenges. As a result of its effectiveness, ExplORer’s technology is now a fully adapted technology within Dr. Karas’ practice.
“ExplORer is a game-changer in surgical efficiency, which I can confidently say after using it for months in my own OR. Surgeons everywhere can leverage this tool in a post-COVID world now focused more on the remote provision of care,” said Dr Vasil Karas. “I am excited to join ExplORer Surgical’s Advisory Board to aid in the company’s growth, bringing this technology to surgeons across the globe and helping them maintain positive patient outcomes. In addition, my partnership as a virtual proctor and trainer with ExplORer for robotic total joint procedures will be extremely important as robotics use continues to grow.”
ExplORer provides meaningful value to an organization’s functions and the surgical teams they work with, including sales, training, medical affairs, marketing, and research and development.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.